Wendy Hunting
Gerontology · Grand Rapids, MINPI 1205486156
Payments from drug & device makers
Across 29 payments — averaging $27.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$95
- GSK$83
- Myriad Genetic Laboratories, Inc.$80
- Takeda Pharmaceuticals U.S.A., Inc.$79
- Eisai Inc.$67
- Merck$44
- plus $348 from 15 others
What the payments were for
- Food & beverage$70188%
- Education$9512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 1 | $95 |
| GSK | 1 | $83 |
| Myriad Genetic Laboratories, Inc. | 1 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $79 |
| Eisai Inc. | 2 | $67 |
| Merck | 3 | $44 |
| Bristol Myers Squibb | 3 | $39 |
| Springworks Therapeutics, Inc. | 2 | $38 |
| Johnson & Johnson | 2 | $37 |
| AstraZeneca | 2 | $37 |
| AbbVie | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Novartis | 1 | $20 |
| Sanofi | 1 | $20 |
| Amgen | 1 | $20 |
| Servier Pharmaceuticals LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Seagen Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Taiho Oncology, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$796 in reported general payments places this provider in the 60th percentile of 279 gerontology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrukinsaZanubrutinib | 12 | $181,150 |
| Imatinib Mesylate | 14 | $57,445 |
| EliquisApixaban | 11 | $6,767 |
| Hydroxyurea | 15 | $608 |
| Acyclovir | 42 | $410 |
| Anastrozole | 15 | $270 |
| Levofloxacin | 11 | $220 |
| Dexamethasone | 11 | $84 |
| Prednisone | 32 | $74 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Grand Rapids
- Angela EmbreeGrand Rapids$10K
- Samantha BurgessGrand Rapids$9K
- Mary GardnerGrand Rapids$8K
- Jennifer LavigneGrand Rapids$6K
- Elizabeth PohlGrand Rapids$5K
- Tanya RowerdinkGrand Rapids$4K
- Lauren JongsmaGrand Rapids$3K
- Lindsey KentGrand Rapids$3K
- Kathryn EllensGrand Rapids$3K
- Kaitlin SchoderGrand Rapids$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.